Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Raj Sripadam is a Consultant Clinical Oncologist at Rutherford Cancer Centre North East and North West. He studied medicine in India before undertaking specialist oncology training at The Clatterbridge Cancer Centre and Velindre Hospital in Cardiff.
Prior to his appointment as a consultant, he was a Clinical Research Fellow at the Academic Department of Radiation Oncology at The Christie Hospital in Manchester where he pursued research in image-guided radiotherapy and gained his Medical Doctorate from the University of Manchester. Dr Sripadam maintains an active interest in research and is the principal investigator for several national breast and gastrointestinal research trials.
Dr Raj Sripadam offers a personalised, patient focussed oncology service to deliver chemotherapy and radiotherapy for colorectal and breast cancers. He also offers some highly specialised services like SABR* (targeted stereotactic radiotherapy) for liver tumours & lymph nodes; contact radiotherapy or papillon treatment and brachytherapy to preserve organ (rectal) function ( i.e. try and avoid a permanent colostomy).
*SABR is not currently available at Rutherford Cancer Centres.
Royal College of Radiologists
European Society of Therapeutic Radiology and Oncology
European Society of Medical Oncology
Association of Radiation
Oncologists of India
Royal College of Radiologists - Fellow
General Medical Council- Member
European Society of Therapeutic Radiology and Oncology - Member
European Society of Medical Oncology - Member
Association of Radiation Oncologists of India - Member
BMJ Cancer care team of the year award 2018
Clinical Excellence award x 2
Dr Raj Sripadam does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Raj Sripadam does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Raj Sripadam does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.